PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 215 filers reported holding PDL BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $243,000 | +39.7% | 48,219 | +77.8% | 0.05% | +62.5% |
Q2 2015 | $174,000 | -8.9% | 27,123 | -0.1% | 0.03% | -11.1% |
Q1 2015 | $191,000 | -79.2% | 27,141 | -77.2% | 0.04% | -79.8% |
Q4 2014 | $920,000 | -29.2% | 119,271 | -23.8% | 0.18% | +19.5% |
Q1 2014 | $1,300,000 | -2.6% | 156,556 | -1.1% | 0.15% | -7.5% |
Q4 2013 | $1,335,000 | +5.7% | 158,256 | -0.2% | 0.16% | -0.6% |
Q3 2013 | $1,263,000 | +3.2% | 158,556 | 0.0% | 0.16% | -3.6% |
Q2 2013 | $1,224,000 | – | 158,556 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Argent Trust Co | 41,405 | $102,270 | 0.01% |
Diversified Trust Co | 11,029 | $26,469 | 0.00% |
HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
Ancora Advisors LLC | 4,948 | $0 | 0.00% |
Westside Investment Management, Inc. | 500 | $0 | 0.00% |